Kopra Bio
Genetically engineered viruses that teach your immune system to kill…
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Modulari-TW23We teach your immune system to attack and cure cancerShared: gene therapy, synthetic biology, biotechActive
Granza BioW24Building programmable therapeutics for the immune systemShared: synthetic biology, biotech, therapeuticsActive
SynsoryBioW24"If-then" conditional logic for protein drugsShared: synthetic biology, biotech, therapeuticsActive
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: biotech, therapeutics, oncologyActive
Guardian BioS22Dendritic cell-based platform for cancer therapyShared: biotech, therapeutics, oncologyActive
Adjacent
Overlapping tags, a different niche.
ParcelBioW24Elevated mRNA for transformative medicines.Shared: gene therapy, synthetic biology, biotechActive
AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: biotech, therapeutics, oncologyActive
Serinus BiosciencesS22Combinations therapy by rational designShared: biotech, therapeutics, oncologyActive
Velorum TherapeuticsW24Breakthrough medicines unlocking the biology of hemeShared: biotech, therapeutics, oncologyActive
Eugit TherapeuticsS22Enabling Tissue Targeting of TherapiesShared: synthetic biology, therapeutics, oncologyActive
Also from S24
Batchmates in Summer 2024.
AminoAnalyticaS24The AI scientist for always-on biodefenseActive
Evolvere BioSciencesS24Making Next-Generation Antibiotics that Outpace Bacterial EvolutionActive
Ligo BiosciencesS24Enzyme design models.Active
Ångström AIS24Gen AI molecular simulations that reproduce wetlab resultsActive
AnthrogenS24We work on generalizable tools for the next era of biotech.Active
Baseline AIS24AI document creation and data management for clinical trialsInactive
About Kopra Bio
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
San Francisco, CA, USA
Kopra Bio: questions
Which YC batch was Kopra Bio in?
Kopra Bio was in Y Combinator's Summer 2024 batch (S24).
Is Kopra Bio still active?
Y Combinator lists Kopra Bio as active.
Where is Kopra Bio based?
Kopra Bio lists San Francisco, CA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.